Condition 1: erectile dysfunction. Condition 2: orgasmic dysfunction. Condition 3: sexual desire dysfunction. Condition 4: intercourse satisfaction disorder. Condition 5: testosterone Serum level. Male erectile disorder Male orgasmic disorder Hypoactive sexual desire disorder Sexual aversion disorder
Conditions
Interventions
Intervention 1: Intervention group: reception of el carnitine 1000mg (manufacturing karen Pharmaceutical Company) once a day after braekfast, for 2months. Intervention 2: Control group: received el-ca
Sponsors
Urmia University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
No minimum to 65 Years
Inclusion criteria
Inclusion criteria: DIalysed men with sexual dysfunction on iief questionnaire age under 65 years old dialysed for at least 6 months dilalysed at least 6 times in 6 months ago the patient be married and have the sustainable sex with his wife
Exclusion criteria
Exclusion criteria: the patient use vitamin k antagonists like as warfarin and other comarin derivatives the patient ha no anatomical problem in his penis the patients be cyrotic the patient dont use SSRIs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in sexual status. Timepoint: Before the intervention, at the end of the first month and at the end of the study. Method of measurement: IIEF questionnaire.;Serum testosterone level. Timepoint: before the intervention and at the end of the study. Method of measurement: immunoassay using direct chemiluminscent tecnology. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in erection condition. Timepoint: Before the intervention, at the end of the first month and at the end of the study. Method of measurement: Questions 1 to 5 and 15 iief questionnaires.;Change in orgasm condition. Timepoint: Before the intervention, at the end of the first month and at the end of the study. Method of measurement: Questions 9 and 10 of the IIEF Questionnaire.;Change in sexual desire. Timepoint: Before the intervention, at the end of the first month and at the end of the study. Method of measurement: Questions 11 and 12 of the IIEF Questionnaire.;Change in intercourse satisfaction. Timepoint: Before the intervention, at the end of the first month and at the end of the study. Method of measurement: Questions 6 to 8 of the IIEF Questionnaire.;Change in overall satisfaction of sexual status. Timepoint: Before the intervention, at the end of the first month and at the end of the study. Method of measurement: Questions 13 and 14 of the IIEF Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfshin Shiva
Oroumia University of Medical Sciences
Outcome results
None listed